Thursday, December 25, 2008

Memory Pharmaceuticals Reports Phase 1 Data For R4996/MEM 63908

Memory Pharmaceuticals Reports Phase 1 Data For R4996/MEM 63908
Memory Pharmaceuticals Corp. (Nasdaq: MEMY) announced positive results from its Phase 1 program for R4996/MEM 63908, a partial agonist of the nicotinic alpha-7 receptor being developed in collaboration with Roche for cognitive disorders such as Alzheimer's disease. The Phase 1 program enrolled over 130 subjects and included a single-ascending dose study, a food interaction study, a study in elderly volunteers and a multiple ascending dose study.

In Early Diagnosis Of Alzheimer's Disease, MRI Brain Scans Accurate
MRI scans that detect shrinkage in specific regions of the mid-brain attacked by Alzheimer's disease accurately diagnose the neurodegenerative disease, even before symptoms interfere with daily function, a study by the Florida Alzheimer's Disease Research Center (ADRC) in Miami and Tampa found.

Wednesday, December 24, 2008

MRSA Infections Continue To Fall, UK

MRSA Infections Continue To Fall, UK
MRSA bloodstream infections in England are continuing to fall, the latest quarterly statistics from the Health Protection Agency (HPA) showed today. There were 725 MRSA bloodstream infections in England between July and September. This represents a 13% decrease on the previous quarter (April to June) when there were 837 cases and a 33% reduction in the corresponding quarter of 2007.

Type 1 Diabetes May Be Triggered By Common Infant Virus
Human parechovirus is a harmless virus which is encountered by most infants and displays few symptoms. Suspected of triggering type 1 diabetes in susceptible people, research methods need to take this "silent" virus into consideration. This comes from findings in a study from the Norwegian Institute of Public Health. This study was part of a long-term project at the Norwegian Institute of Public Health to investigate if environmental risk factors affect type 1 diabetes.

VLST Corporation And Novo Nordisk Announce Collaboration Agreement To Develop Therapeutics For Autoimmune And Inflammatory Disorders
Novo Nordisk and VLST Corporation, a Seattle-based biotechnology company focused on the development of therapeutics for autoimmune and inflammatory disorders, announced that the companies have entered into an exclusive, worldwide collaboration agreement to develop therapeutic targets utilizing VLST's technology platform in the fields of autoimmune and inflammatory disorders.

Practice Food Safety To Prevent Food-Borne Illness During Holidays
Food safety is important year round but a state health official reminds South Dakotans to pay particular attention as they entertain family and friends at holiday gatherings. "Bacterial food-borne illness, more commonly called food poisoning, can be prevented with common sense measures such as thorough hand washing, cooking and storing foods at the proper temperature, and avoiding food preparation when you're sick," said Dr.

LSUHSC's Hill Selected As Fellow Of AAAS
James M. Hill, PhD, Professor of Ophthalmology, Pharmacology, Microbiology, and Neuroscience at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded the distinction of American Association for the Advancement of Science (AAAS) Fellow. Election as a Fellow is an honor bestowed upon AAAS members by their peers. Dr.

E. coli In The Urinary Tract
Transfer of information is a basic property of biological systems. Common examples include transfer of genetic information or nerve impulses Transmission of signals occurs at an even more fundamental level between and within cells, including signaling molecules, which bear a phosphate or a sulfate group. The latter contain a sulfur atom.

Blocking The Spread Of Antibiotic Resistance In Bacteria
It's as simple as A, T, G, C. Northwestern University scientists have exploited the Watson-Crick base pairing of DNA to provide a defensive tool that could be used to fight the spread of antibiotic resistance in bacteria - one of the world's most pressing public health problems. The resistant nasty pathogens cause thousands of deaths each year in the United States.

Tuesday, December 23, 2008

New Interventions Added to the Updated Compendium of Evidence-Based Interventions

The ongoing PRS efficacy review process has identified 57 evidence-based HIV behavioral interventions (as of May 2008). On December 19, 2008, eight new intervention fact sheets were added. Read more ...